NOVN.SW
$115.60-1.28 (-1.10%)
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
Recent News
Health Care Roundup: Market Talk
Find insight on Novartis, Chulurat Hospital and more in the latest Market Talks covering Health Care.
Stocks to Watch Recap: Super Micro Computer, FedEx, Unilever
↗️ FedEx (FDX): The shipping company raised its outlook as revenue increased in the fiscal third quarter. Shares rose 0.8%. ↘️ Super Micro Computer (SMCI): The technology company placed two employees on leave and fired a contractor after learning of their alleged involvement in a scheme to divert computer servers assembled in the U.
Novartis Strikes $3B Oncology Deal for Breast Cancer Asset
NVS bets $2B upfront on SNV4818 to expand precision oncology in breast cancer, targeting a large mutation-driven market and boosting long-term pipeline growth.
Will the Recent Label Expansion of BMY's Sotyktu Boost Its Prospects?
BMY's Sotyktu PsA approval boosts its immunology push, expands market reach, and sharpens its competitive stance amid pressure from legacy drug declines.
Novartis Agrees Up to $3 Billion Synnovation Breast Cancer Drug Deal
Swiss drugmaker commits $2 billion upfront plus milestones to acquire early-stage HR+/HER2- therapy, reinforcing its oncology pipeline.